Joseph Emile Eid's most recent trade in Geron Corp. was a trade of 2,220,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geron Corp | Joseph Emile Eid | EVP, R&D; Chief Medical Office | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2026 | 2,220,000 | 2,220,000 | - | - | Stock Option (Right to Buy) | |
| Geron Corp | Joseph Emile Eid | EVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2024 | 2,500,000 | 2,500,000 | - | - | Stock Option (right to buy) |